Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LIMN compared with BURU: revenue, margins and what each company keeps, and the suppliers and customers both name
LIMN
Liminatus Pharma, Inc.
Change
Mkt cap
Revenue
Revenue
BURU
Nuburu, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LIMN
Liminatus Pharma, Inc.
vs
BURU
Nuburu, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
LIMN
No earnings history for LIMN.
BURU
Report
implied
realized
× implied
Nov 10 '23
—
▼
−44.03%
—
Aug 11 '23
—
▼
−21.69%
—
May 12 '23
—
▼
−11.46%
—
Mar 9 '23
—
▼
−9.01%
—
= implied
LIMN realized, solid
BURU realized, hatched
One scale, both sides: full bar = 45%
× = |realized| ÷ implied
Source: market data
LIMN
Liminatus Pharma, Inc.
Change
2.59
▼
−1.52%
· post 2.52
Mkt cap
$2.5M
Revenue
—
BURU
Nuburu, Inc.
Change
0.21
▲
+8.07%
· post 0.21
Closed
Nov 6 '26
Mkt cap
$1.0M
Revenue
$524,927
Q2 FY26
vs
Compare
Closed
Nov 6 '26
LIMN
Liminatus Pharma, Inc.
vs
BURU
Nuburu, Inc.
2.59
▼
−1.52%
post 2.52
Price
0.21
▲
+8.07%
post 0.21
$2.5M
Mkt cap
$1.0M
—
Revenue
$524,927
Q2 FY26
Change
Change
LIMN
2.59
▼
−1.52%
vs
BURU
0.21
▲
+8.07%
Closed
Nov 6 '26